Source: Annual Congress 2011 - Experimental pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Ichimori, S. Kogaki, K. Takahashi, K. Ozono (Suita, Japan). Roles of sex hormones on bone morphogenetic protein signaling in pulmonary artery differed between testosterone and estrogen. Eur Respir J 2011; 38: Suppl. 55, 3336

Member's Comments

No comment yet.

Related content which might interest you: Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females Source: Eur Respir J 2009; 34: 1093-1099 Year: 2009 Dysregulated bone morphogenetic protein signaling in pulmonary arterial hypertension Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension Year: 2008 Inhibiting oestrogen signalling in pulmonary arterial hypertension: sex, drugs and research Source: Eur Respir J, 50 (2) 1700983; 10.1183/13993003.00983-2017 Year: 2017 The adverse effect of estrogen on bone morphogenetic protein receptor (BMPR) signal pathway in pulmonary arterial endothelial cells (PAEC) Source: Annual Congress 2009 - Pulmonary circulation II Year: 2009 Targeting bone morphogenic protein receptor 2 (BMPR2) signalling to treat pulmonary arterial hypertension Source: Eur Respir J, 50 (3) 1701370; 10.1183/13993003.01370-2017 Year: 2017 Mutations in the bone morphogenic protein receptor 2 promoter in heritable pulmonary arterial hypertension Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018 Bone morphogenetic protein signalling in heritable versus idiopathic pulmonary hypertension Source: Eur Respir J 2009; 34: 1100-1110 Year: 2009 Oestradiol metabolism and androgen receptor genotypes are associated with right ventricular function Source: Eur Respir J 2016; 47: 553-563 Year: 2016 Bone morphogenetic protein receptor-II as a regulator of pulmonary artery endothelial cell permeability: Relevance to the initiation and progression of heritable pulmonary arterial hypertension Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension Year: 2010 Thyroid hormone is highly permissive in angioproliferative pulmonary hypertension in rats Source: Eur Respir J 2013; 41: 104-114 Year: 2013 Beyond oestrogens: towards a broader evaluation of the hormone profile in pulmonary arterial hypertension Source: Eur Respir J, 51 (6) 1801058; 10.1183/13993003.01058-2018 Year: 2018 The microRNA cluster 17/92 regulates the expression of the bone morphogenetic protein receptor type II involved in the pathogenesis of pulmonary hypertension Source: Annual Congress 2009 - Pathobiology of pulmonary hypertension Year: 2009 Growth hormone releasing hormone-receptor antagonist MIA-602 modulates lung inflammation, cellular signal transduction, and promotes apoptosis of mouse lung fibroblasts Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020 The effect of estrogen and its receptor on hypoxic pulmonary vascular remodeling Source: Eur Respir J 2006; 28: Suppl. 50, 658s Year: 2006 Endocrinological disturbances in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: 76S-80S Year: 2003 The influence of glucocorticoid therapy on the level of sex hormones in menopausal women with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 51s Year: 2002 Oral presentation: The bone morphogenetic protein antagonist Gremlin in pulmonary hypertension Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis Year: 2009 Local expression of hormone receptors seems to play a role in the genesis of idiopathic tracheal stenosis Source: International Congress 2017 – From respiratory muscles to acute respiratory failure Year: 2017 Endocrinological derangements in COPD Source: Eur Respir J 2009; 34: 975-996 Year: 2009